当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2016年第5期
编号:12770490
多发性骨髓瘤患者血清乳酸脱氢酶和C反应蛋白检测及临床意义(4)
http://www.100md.com 2016年2月15日 中国医药导报 2016年第5期
     [15] Pavlu J,Auner HW,Ellis S,et al. LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma:treatment outcome and risk factor analysis from a single centre [J]. Hematol Oncol,2011,29(2):75-80.

    [16] Verma GR,Thiagarajan S,Gupta R,et al. Thrombocytosis and raised CRP levels predicts advanced stage in esophageal carcinoma [J]. J Gastrointest Cancer,2015,46(4):350-355.

    [17] Babaei Z,Moslemi D,Parsian H,et al. Relationship of obesity with serum concentrations of leptin,CRP and IL-6 in breast cancer survivors [J]. J Egypt Natl Canc Inst,2015,27(4):223-229.

    [18] Graff JN,Beer TM,Liu B,et al. Pooled analysis of C-reactive protein levels and mortality in prostate cancer patients [J]. Clin Genitourin Cancer,2015,13(4):e217-e221.

    [19] Alexandrakis MG,Passam FH,Ganotakis ES,et al. The clinical and prognostic significance of erythrocyte sedimentation rate(ESR),serum interleukin-6(IL-6)and acute phase protein levels in multiple myeloma [J]. Clin Lab Haematol,2003,25(1):41-46.

    [20] Hong S,Kang YA,Cho BC,et al. Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer [J]. Yonsei Med J,2012,53(1):111-117.

    (收稿日期:2015-11-01 本文编辑:张瑜杰), http://www.100md.com(张浩然 毕明宏 翟云芝 等)
上一页1 2 3 4